Analyst Activity – Maxim Group Reiterates Buy on Anavex Life Sciences Corp. (NASDAQ:AVXL)

ME Staff
-
0

Analyst Ratings For Anavex Life Sciences Corp. (NASDAQ:AVXL)

Today, Maxim Group reiterated its Buy rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) with a price target of $15.00.

There are 3 buy ratings on the stock.

The current consensus rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) is Buy (Score: 3.00) with a consensus target price of $13.67 per share, a potential 180.63% upside.

Some recent analyst ratings include

  • 7/20/2017-Maxim Group Reiterated Rating of Buy.
  • 5/14/2017-Noble Financial Reiterated Rating of Buy.
  • 10/5/2016-FBR & Co Reiterated Rating of Outperform.

Recent Insider Trading Activity For Anavex Life Sciences Corp. (NASDAQ:AVXL)
Anavex Life Sciences Corp. (NASDAQ:AVXL) has insider ownership of 11.60% and institutional ownership of 22.78%.

  • On 7/14/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.52 per share and the total transaction amounting to $520.00. View SEC Filing
  • On 7/13/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.53 per share and the total transaction amounting to $530.00. View SEC Filing
  • On 7/7/2015 Christopher U Missling, CEO, bought 2,000 with an average share price of $0.49 per share and the total transaction amounting to $980.00. View SEC Filing
  • On 7/1/2015 Christopher U Missling, CEO, bought 2,000 with an average share price of $0.45 per share and the total transaction amounting to $900.00. View SEC Filing
  • On 6/23/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.47 per share and the total transaction amounting to $470.00. View SEC Filing
  • On 6/22/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.42 per share and the total transaction amounting to $420.00. View SEC Filing
  • On 6/16/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.44 per share and the total transaction amounting to $440.00. View SEC Filing

Recent Trading Activity for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Shares of Anavex Life Sciences Corp. closed the previous trading session at 4.87 down -0.13 -2.60% with 580,945 shares trading hands.